Recurrent T Lymphoblastic Lymphoma

1 clinical trials · Condition

Record	Firm	Date
Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia (NCT03504644)	ECOG-ACRIN Cancer Research Group	2018-08-13

Every clearance here is in the API, with alerts when new ones post.